Brand
ScarAway

ScarAway is described as the leading silicone-based scar-treatment brand in the US, built around medical-grade silicone gels and sheets. Alliance Pharma, a UK-listed international healthcare group, acquired ScarAway and the US rights to Kelo-cote from Perrigo in 2020.
Alliance Pharma plc, Chippenham, United Kingdom
Owned by Alliance Pharma (since 2020)
Ownership and scale
Alliance Pharma acquired ScarAway, along with the US rights to Kelo-cote, from Perrigo for about 14.8 million pounds (roughly $19 million). Alliance Pharma is a publicly listed UK healthcare group (AIM: APH). A standalone ScarAway valuation beyond that deal is not separately disclosed.
Brand timeline
2020
Alliance Pharma acquires ScarAway and US Kelo-cote rights from Perrigo for about 14.8 million pounds
2020s
The range expands across silicone sheets, gel, spray, and C-section lines
Where to buy
Where to get the best offers
A drugstore brand, so value comes from retailer sales, variety packs, and multipacks on Amazon; the silicone sheets are reusable, which lowers the effective cost.
ScarAway products we have reviewed
Silicone Clear Scar Sheets
ScarAway
Key Ingredient
Medical-grade silicone
Silicone Scar Gel
ScarAway
Key Ingredient
Medical-grade silicone
Silicone Scar Sheets for C-Sections
ScarAway
Key Ingredient
Medical-grade silicone
Brand background is compiled from public sources. Ownership and valuation figures are reported acquisitions or valuations where disclosed; private brands are marked as not publicly disclosed. Prices and retailers change, so confirm on the brand's official page.